Ubiquiti Inc. Reports First Quarter Fiscal 2024 Financial Results
~ Revenues of $463.1 million ~ ~ GAAP Diluted Earnings Per Share of $1.45 ~ NEW YORK–(BUSINESS WIRE)–Ubiquiti Inc. (NYSE: UI) (“Ubiquiti”... Read more.
SkyWater Announces Availability of Cadence Open-Source PDK and Reference Design for SkyWater’s 130 nm Process
Available in Cadence’s CMOS VLSI design course, PDK aids semiconductor education programs, supporting workforce development initiatives BLOOMINGTON, Minn.–(BUSINESS... Read more.
Velsera and Solaris Health Partner to Expand Access to Genetic Testing that Helps Urology Patients Understand Cancer Risks
Solaris Health Affiliates Using Velsera’s Leading Genetic Interpretation and Clinical Reporting Platform to Offer Inherited Cancer Testing Through Their Own... Read more.
Momentus Completes Vibration Testing of Vigoride-7 Orbital Service Vehicle
Spacecraft scheduled to fly on SpaceX’s Transporter-10 Mission SAN JOSE, Calif.–(BUSINESS WIRE)–Momentus Inc. (NASDAQ: MNTS) (“Momentus”... Read more.
FiscalNote to Report Third Quarter Financial Results on November 14
WASHINGTON–(BUSINESS WIRE)–FiscalNote Holdings, Inc. (NYSE: NOTE) (“FiscalNote”), a leading AI-driven enterprise technology provider of global... Read more.
TELUS International reports third quarter 2023 results, demonstrating steady revenue growth, improved profitability versus prior quarter, and reaffirms full-year outlook for 2023
VANCOUVER, British Columbia–(BUSINESS WIRE)–TELUS International (NYSE and TSX: TIXT), a leading digital customer experience innovator that designs,... Read more.
GrafTech Reports Third Quarter 2023 Results
Results and Near-term Outlook Reflect Persistent Softness in the Commercial Environment BROOKLYN HEIGHTS, Ohio–(BUSINESS WIRE)–GrafTech International... Read more.
MarketAxess Announces Monthly Volume Statistics for October 2023
NEW YORK–(BUSINESS WIRE)–MarketAxess Holdings Inc. (Nasdaq: MKTX), the operator of a leading electronic trading platform for fixed-income securities,... Read more.
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee... Read more.
inTEST Reports Record $32.7 Million in Revenue for the 2023 Third Quarter with Earnings per Diluted Share up 4% to $0.24 Year-over-Year
Continued execution of Five-Point Strategy delivers third quarter revenue of $32.7 million, up 6% year-over-year while relatively unchanged from trailing second... Read more.